THE USE OF THE E-ROSETTE AS A TEST FOR REMISSION IN GRAVES’DISEASE TREATED WITH ANTITHYROID DRUGS
- 1 January 1974
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 3 (1), 55-61
- https://doi.org/10.1111/j.1365-2265.1974.tb03296.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- INCREASE OF T CELLS IN GRAVES' DISEASEThe Lancet, 1973
- Peripheral Thymus-Dependent (T) Lymphocytes in Graves's Disease and Hashimoto's ThyroiditisNew England Journal of Medicine, 1973
- Cell-Mediated Immunity in Graves' Disease and in Hashimoto's Thyroiditis as Shown by the Demonstration of Migration Inhibition Factor (MIF)1Journal of Clinical Endocrinology & Metabolism, 1973
- The Immunologic Basis of Graves's DiseaseNew England Journal of Medicine, 1972
- SURFACE MARKERS ON HUMAN T AND B LYMPHOCYTESThe Journal of Experimental Medicine, 1972
- SUBPOPULATIONS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES DISTINGUISHED BY COMBINED ROSETTE FORMATION AND MEMBRANE IMMUNOFLUORESCENCEThe Lancet, 1972
- Thyroid Suppressibility: Follow-up for Two Years after Antithyroid TreatmentBMJ, 1971
- Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugsMetabolism, 1969
- EMOTION AND NON-SPECIFIC INFECTION AS POSSIBLE ÆTIOLOGICAL FACTORS IN GRAVES' DISEASEThe Lancet, 1968
- Development of Thyroidal Suppression by Triiodothyronine During Six Months' Treatment of Thyrotoxicosis with Antithyroid DrugsJournal of Clinical Endocrinology & Metabolism, 1967